Case conference March, 28th 2012
29-Mar-2012, Divisi Ginekologi Onkologi RSCMOncology case conference march 25th 2012
Mrs. Siti N, 49 yo
Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage
• CC: bring lab result (Ca125 119)
• 8/5/11: came with cystic ovarian neoplasm susp malignancy (Ca 125 354.9)
• 19/5/11:Cytology ascitesà adenocarcinoma
• 8/6 until 28/7/2011:Chemoth/CP 3x, Ca 125 40.7
• 28/9/11: post NAC 3 series,
– Stable disease
– Resectable (+), plan for laparotomy
• 10/11/11: optimal debulking (TAH BSO, total omentectomy, right paracolic peritonectomy, tumor implant excision, appendectomy)
• 22/11/11: PA result shows clear cell carcinoma with poor differentiation
• 18/1/12: change chemoth/ with carbo-paclitaxel 3 series (25/1 until 7/3)
Physical exam
Compos mentis
BP 120/70 mmHg Pulse 89x/min
RR 18x/min T 36.8
• Conjunctiva : not anemic
• Heart/lung : wnl
• Abdomen : wnl
• Extremities : edema -/-
Gynecological status
• Inspection : wnl
• Inspeculo : smooth vaginal stump, no mass
• VRE :smooth vaginal stump, no palpable mass, TSMA wnl
US May 13 2011 (before NAC)
- Anteflexed uterus with multiple intramural myoma size 28-38 mm. Regular endometrium.
- Cystic mass on right adnexa with solid part, irregular shape and border, RI 0.28 could be originated from right ovarian neoplasm
- Normal left ovary
- Liver, spleen and both kidney normal
- Ascites (+)
Conclusion :
Ascites and cystic mass with solid part of the right ovary, suspected malignancy
US August 22 2012( post NAC 3 series)
- anteflexed uterus with multiple intramural and subserous myoma size 27-46 mm. Regular endometrium.
- right adnexa : cystic mass with solid part, regular size and shape, size 182x110x184 mm (vol~1950 cc), neovascularization (+) RI 0.37 ~ right ovarian neoplasm.
- Normal left ovary.
- Ascites (-).
- Normal liver, spleen, both kidney and bladder.
Conclusion :
- Intramural and subserous myoma
- Cystic neoplasm with solid part suspected malignancy (from previous ultrasound, mass volume is getting bigger).
US March 20 2012 (post Adjuvant chemotherapy 3x)
• Conclusion: no new mass visualized
Ca 125 (March, 21 2012) : 119
Diagnosis
• Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage
Problem
• Post optimal debulking + 3x NAC and 3x adjuvant chemoth (carboplatin+paclitaxel) due to ovarian cancer (clear cell) advance stage, complete response
• Increased ca 125 level ( 119) and no mass on US
Plan
• Continue chemotherapy 3 series or observation??
Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013
13-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 13th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
20-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 20th 2013
13-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 113th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
Index News